Success Stories: A Ph.D. Student Acquires EB1A and NIW Cases Approval Just 1 Month and 14 Days Apart, No RFE Issuance
Client’s Testimonial:
“I am incredibly grateful for the support and expertise my attorney provided. They were professional, responsive, and truly understood my needs. Thanks to their hard work, we achieved a successful outcome.”
On January 31st, 2024 and March 14th, 2024, we received another EB-1A (Alien of Extraordinary Ability) and EB-2 NIW (National Interest Waiver) Approval for a Ph.D. Student in the Field of Microbiology (Approval Notice).
General Field: Microbiology
Position at the Time of Case Filing: Ph.D. Student
Country of Origin: China
State of Residence at the Time of Filing: Illinois
Approval Notice Date: January 31st, 2024 (EB1A) and March 14th, 2024 (NIW)
Processing Time: 7 days (EB1A) (Premium Processing Requested) and 6 months, 3 days (NIW)
Case Summary:
One of the few top authorities in the field of microbiology, our client, came to North America Immigration Law Group seeking assistance in demonstrating his long history of success and influence in his field of study as well as his noteworthy contributions to the United States. The group worked with him to develop a compelling EB-2 NIW (National Interest Waiver) petition. We found that our client is interested in using genome-wide clustered regularly interspaced short palindromic repeats (CRISPR) screens to identify critical host factors for coronavirus replication. This is because it is part of our job to assess our client's qualifications and research background to validate the veracity of his credentials.
Moreover, we noted that he has received at least 641 citations for his work, a high number of them from colleagues. We filed his accomplishments for the NIW petition, and he then hired us to put together an additional EB-1A (Alien of Extraordinary Ability) visa petition. We thus decided to take the case, and we highlighted his exceptional background and unique experience to USCIS which will be valuable to our client’s position going forward.
Upon reviewing his credentials further, we noted that his research resulted in 9 peer-reviewed journal articles (3 first) and these papers have been published in some of the most discerning, high-impact journals in his field. Moreover, he has conducted at least 11 reviews for highly acclaimed journals to date. This impartial proof demonstrates his genuine and active involvement in evaluating the work of other experts in the field of microbiology. He definitely satisfies this requirement in light of the aforementioned facts.
Furthermore, our objective was to demonstrate our client’s entry to the United States will substantially benefit prospectively the United States by focusing on identifying critical host factors for coronavirus replication and has already greatly advanced the national interest by using genome-wide CRISPR screens to identify host factors in SARS-CoV-2, which addresses some of the world’s most pressing issues, including understanding host-virus interactions and emerging pathogens, improving emergency preparedness, and mitigating the progression of diseases.
Besides, his study has received funding from the NIH, Roddenberry Foundation, DARPA, and Roche. This funding supports projects that improve human health and biology research. Therefore, his research clearly advanced the goals of these organizations through his work on identifying host factors essential for coronavirus replication.
The steps our team took to pursue USCIS in these cases were effective, and because of our client's extensive experience and rigorous training, prominent publications sought his expertise in the field. Thus, we were successful in proving that our client’s work is dedicated to advances in microbiology, which are matters of critical national importance. Researchers who are highly skilled in this area are thus crucial to the United States. As such, the very best and brightest researchers should be employed in these tasks, and our client is one such researcher.
We would like to congratulate our client on securing both the I-140 approvals. We extend a special thanks to the Premium Processing service upgrade for his EB1A case, which was adjudicated in only 7 days instead of the expected 9-12 months. We also wish him well in his future undertakings.